7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with Infections, Helicobacter in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, H; Epplein, M; Gao, YT; Lan, Q; Li, HL; Michel, A; Milne, G; Pawlita, M; Rothman, N; Shu, XO; Wang, T; Xiang, YB; Zheng, W | 1 |
Abnet, CC; Chow, WH; Dong, LM; Gao, YT; Ji, BT; Li, HL; Milne, G; Rothman, N; Shu, XO; Yang, G; Zheng, W | 1 |
1 trial(s) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Infections, Helicobacter
Article | Year |
---|---|
Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
Topics: Adult; Aged; Biomarkers, Tumor; Case-Control Studies; China; Cohort Studies; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Prostaglandins; Risk Factors; Stomach Neoplasms; Women's Health | 2009 |
1 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Infections, Helicobacter
Article | Year |
---|---|
A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
Topics: Adult; Aged; Antibodies, Bacterial; Antigens, Bacterial; Case-Control Studies; China; Chromatography, Liquid; Cohort Studies; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Logistic Models; Male; Middle Aged; Odds Ratio; Prospective Studies; Prostaglandins; Recombinant Fusion Proteins; Risk Factors; Serology; Stomach Neoplasms; Tandem Mass Spectrometry | 2017 |